Microba Life Sciences today announced that all participants have been successfully dosed in the Phase I Clinical Trial of MAP 315, in Microba's The...
Our leadership teamGlobally leading experts driving the precision and application of our technologyLearn more
Human first, data-driven therapeutic discoveryGenerating multiple therapeutic leads to address unmet needs for major chronic diseasesLearn more
Driving discovery in microbiome researchEmpowering researchers with world-leading technology and expertise to make new discoveriesLearn more
Our platform technologies are driving new solutions for improving human health
“Testing, understanding and modifying the microbiome is key to addressing many diseases and improving our health. Microba’s leading technology is driving this health transformation.”— Professor Ian Frazer, Chair of Medical Advisory Board
Partner with us
Through partnerships with leading organisations worldwide, we are powering the discovery of new relationships between the microbiome, health and disease for the development of new health solutions.Speak with our team